Home Newsfeeds Mizuho Maintains Neutral on Microchip Technology, Lowers Price Target to $72

Mizuho Maintains Neutral on Microchip Technology, Lowers Price Target to $72

Mizuho analyst Vijay Rakesh maintains Microchip Technology (NASDAQ:MCHP) with a Neutral and lowers the price target from $75 to $72.

byBenzinga Newsdesk

November 4, 2022

1 minute read

Mizuho analyst Vijay Rakesh maintains Microchip Technology (NASDAQ:MCHP) with a Neutral and lowers the price target from $75 to $72.

RBC Capital Maintains Outperform on Cargojet, Lowers Price Target to C$231

By Benzinga Newsdesk

March 7, 8:51 AM

RBC Capital analyst Walter Spracklin maintains Cargojet (TSX:CJT) with a Outperform and lowers the price target from C$247 to C$231.

TSX:CJT

Why These Apple Analysts Have Reduced Their Price Targets Ahead Of Results

By Lisa Levin

October 18, 11:23 AM

Apple Inc. (NASDAQ: AAPL) is expected to report quarterly earnings on October 27, 2022. Analysts expect the company reporting earnings at $1.27 per share on revenue of $88.9 billion. However, several analysts lowered price targets on Apple recently.

AAPL

A Look Into Kimberly-Clark Inc’s Price Over Earnings

By Benzinga Insights

January 8, 4:00 PM

Looking into the current session, Kimberly-Clark Inc. (NYSE:KMB) shares are trading at $122.91, after a 0.54% increase. Moreover,…

KMB

Inspire Medical Systems Increases FY22 Revenue $384M-$388M vs $361.78M Est

By Benzinga Newsdesk

November 1, 4:08 PM

Full Year 2022 Guidance Given the positive trends during the third quarter, Inspire is increasing its full year 2022 revenue guidance to

INSP

Mizuho Maintains Neutral on Microchip Technology, Lowers Price Target to $72

Related Posts

RBC Capital Maintains Outperform on Cargojet, Lowers Price Target to C$231

Why These Apple Analysts Have Reduced Their Price Targets Ahead Of Results

A Look Into Kimberly-Clark Inc’s Price Over Earnings

Inspire Medical Systems Increases FY22 Revenue $384M-$388M vs $361.78M Est